Stephen J. Di Martino, MD, PhD

Dr. Stephen J. Di Martino specializes in the treatment of myositis, rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, and osteoarthritis. He is actively involved in clinical research on myositis treatment and serves as the Medical Advisor to the Hospital for Special Surgery Myositis Support Group. Dr. Di Martino completed his fellowship in Rheumatology at HSS, and is board certified in Internal Medicine and Rheumatology.

Appointments

Assistant Attending Rheumatologist, Hospital for Special Surgery
Instructor in Clinical Medicine, Weill Cornell Medical College

Specialty

Rheumatology

Special Expertise

Myositis
Rheumatoid arthritis
Systemic lupus erythematosus
Psoriatic arthritis
Osteoarthritis

Affiliations

American College of Rheumatology
Hospital for Special Surgery Myositis Support Group - Medical Advisor

Education

MD/PhD, State Univertisty of New York at Stony Brook School of Medicine, 1999

Internship

New York Presbyterian Hospital, Cornell Campus, 1999-2000

Residency

New York Presbyterian Hospital, Cornell Campus, 2000-2001

Fellowship

Hospital for Special Surgery, 2001-2005

Certification

Internal Medicine, 2002
Rheumatology, 2004

State Licensure

New York  

Stephen J. Di Martino, MD, PhD has contributed to the following articles on HSS.edu:

Selected Publications

Di Martino, SJ. Idiopathic Inflammatory Myopathy: Treatment Options. Current Rheumatology Reports 10(4):321-7, 2008.

Di Martino, SJ. Stronger Decision Making in Myositis. Journal of Musculoskeletal Medicine, 2008.

Di Martino, SJ; Yuan, W; Redecha, P; Ivashkiv, LB; Salmon, JE. Insoluble Immune Complexes are Most Effective at Triggering IL-10 Production in Human Monocytes and Synergize with TLR Ligands and C5a. Clinical Immunology 127(1):56-65, 2008.

Di Martino, SJ; Trujillo, G; McVoy, LA; Kew, RR. Upregulation of Vitamin D Binding Protein (Gc-Globulin) Binding Sites During Neutrophil Activation from a Latent Reservoir in Azurophil Granules. Molecular Immunology 44(9):2370, 2007.

Di Martino, SJ; Kagen, LJ. Newer Therapeutic Approaches: Inflammatory Muscle Disorders. Rheumatic Disease Clinics of North America 32: 121, 2006.

Shah, AB; Di Martino, SJ; Trujillo G; Kew, RR. Selective inhibition of the C5a chemotactic cofactor function of the vitamin D binding protein by 1,25(OH)2 vitamin D3.  Molecular Immunology 43(8):1109-15, 2006.

Di Martino, SJ; Paget, SA. On the Importance of Early Arthritis Centers. HSS Journal 1:107, 2005.

For more publications, please see the PubMed listing.

Selected Books/Chapters

Di Martino, SJ and Ivashkiv, LB. Therapeutic targets for the treatment of autoimmune disease. In: Yee, A, Paget, SA, editors. Expert Guide to Rheumatology. Philadelphia; American College of Physicians, 2004.  

Research Description

Dr. Di Martino is involved with the following clinical trials.

RIM: Rituximab in the treatment of Myositis, Chester Oddis, MD; Ann Reed, MD
Site principle investigator: To determine the effects of rituximab in refractory polymyositis and dermatomyositis

RAVE: Rituximab for ANCA-associated Vasculitis, Robert Spiera, MD (site PI)
Site co-investigator: To determine the effect of rituximab on remission induction in patient with ANCA-associated vasculitis

Research Interests

Inflammatory Myopathy